Aniara Corporation Product Pipeline Analysis
| Publication Date | May 2008 |
|---|---|
| Publisher | Global Markets Direct |
| Product Type | Report |
| Pages | 28 |
| ISBN Number | not applicable |
| Product Code | GMD04757 |
Summary
This report is an insightful source for data, analysis and strategic insights into a Aniara Corporation's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reason to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.
Content
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Industry Outlook - In Vitro Diagnostics
- 3 Aniara Corporation Pipeline Products
- 3.1 Aniara Corporation Product Pipeline Analysis
- 3.1.1 Aniara Corporation Pipeline Products By Equipment Type
- 3.1.2 Aniara Corporation Pipeline Products By Development Stage
- 3.1.3 Aniara Corporation Pipeline Products By Therapy Area
- 3.2 Elisa Factor VII kit
- 3.2.1 Product Description
- 3.2.2 Product Status
- 3.3 Elisa Factor VIII kit
- 3.3.1 Product Description
- 3.3.2 Product Status
- 3.4 Global Body's Fibrinolytic Capacity Assay
- 3.4.1 Product Description
- 3.4.2 Product Status
- 3.5 Third Generation TAFI EIA
- 3.5.1 Product Description
- 3.5.2 Product Status
- 3.6 Collagen Binding Activity Elisa
- 3.6.1 Product Description
- 3.6.2 Product Status
- 3.7 D-Dimer
- 3.7.1 Product Description
- 3.7.2 Product Status
- 3.8 Protein S (Free)
- 3.8.1 Product Description
- 3.8.2 Product Status
- 3.9 Von Willebrand Factor
- 3.9.1 Product Description
- 3.9.2 Product Status
- 3.10 Prothrombin
- 3.10.1 Product Description
- 3.10.2 Product Status
- 3.11 Neurological Disorders (Anti-Gangliosides)
- 3.11.1 Product Description
- 3.11.2 Product Status
- 3.12 Antithrombin III
- 3.12.1 Product Description
- 3.12.2 Product Status
- 3.13 PAI-1 Chromogenic
- 3.13.1 Product Description
- 3.13.2 Product Status
- 3.1 Aniara Corporation Product Pipeline Analysis
- 4 Business Description
- 4.1 Business Overview
- 4.2 Major Products and Services
- 4.2.1 Overview
- 5 Competitors
- 6 Key Employees
- 7 Key Employee Biographies
- 8 Locations And Subsidiaries
- 8.1 Head Office
- 8.2 Other Locations & Subsidiaries
- 9 Recent Developments
- 9.1 Strategy and Business Planning
- 9.1.1 Sep 02, 2007: Aniara To Research Product Line Of Hyphen
- 9.2 Product Announcements
- 9.2.1 Sep 02, 2007: Aniara To Research Product Line Of Hyphen
- 9.1 Strategy and Business Planning
- 10 Appendix
- 10.1 Methodology
- 10.1.1 Coverage
- 10.1.2 Secondary Research
- 10.1.3 Primary Research
- 10.1.4 Expert Panel Validation
- 10.2 Contact Us
- 10.3 About Global Markets Direct
- 10.4 Disclaimer
- 10.1 Methodology
- List of Tables
- Table 1: Aniara Corporation,Key Facts
- Table 2: Aniara Corporation Pipeline Products by Equipment Type
- Table 3: Aniara Corporation Pipeline Products By Development Stage
- Table 4: Aniara Corporation Pipeline Products By Therapy Area
- Table 5: Aniara Corporation, Key Employees,
- Table 6: Aniara Corporation, Other Locations
- List of Figures
- Figure 1: Global Markets Direct Methodology
About this Product
Delivery Details
PDF:Delivered by email usually within 24 to 48 UK business hours.
Product features / use
| Scope | Expert Insight/Opinion | ![]() |
| Features | Primary Research Data | ![]() |
Related Products
Recently Viewed Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories
















